AML Medical Science Liaison - Field-Based Exchange

IQVIA LLC; Parsippany-Troy Hills (NJ); On-site; USD 170,000 - 210,000; Full time

Job summary

IQVIA is seeking experienced Medical Science Liaisons to support a late-stage AML program. The MSL will engage with investigators, hematologists, oncologists, and other healthcare professionals, serving as a field-based scientific resource for exchanging clinical data and gathering insights on MRD, relapse risk, and evolving guidelines.

The role emphasizes scientific exchange, partnering with Medical Affairs, and cross-functional collaboration.

Qualifications

• Advanced degree required; PharmD/MD/DO/PhD or equivalent strongly preferred.
• Minimum 4 years of MSL experience or clinical development experience in hematology/oncology.
• Minimum 3 years hematology/oncology experience with therapeutic area expertise.

Responsibilities

• Develop and maintain scientific relationships with investigators and KOLs across the assigned territory.
• Engage in compliant, peer-to-peer scientific discussions regarding AML and related hematologic malignancies.
• Communicate complex clinical information to diverse external stakeholders and support medical education programs.
• Partner with Medical Affairs and cross-functional teams to execute field medical plans and knowledge management.

Skills

MSL experience

Hematology/oncology expertise

Effective communication

CRM proficiency

Education

Advanced clinical or scientific degree (PharmD, MD, DO, PhD, DNP, NP, PA, or equivalent)

Tools

CRM platforms

Microsoft Office Suite

Microsoft Teams

Job description

IQVIA is seeking experienced Medical Science Liaisons to support a late-stage AML program. The MSL will engage with investigators, hematologists, oncologists, and other healthcare professionals, serving as a field-based scientific resource for exchanging clinical data and gathering insights on MRD, relapse risk, and evolving guidelines.

The role emphasizes scientific exchange, partnering with Medical Affairs, and cross-functional collaboration.